期刊文献+

Comparison of Dosiology between Three Dimensional Conformal and Intensity-modulated Radiotherapies (5 and 7 fields) in Gastric Cancer Post-surgery 被引量:1

Comparison of Dosiology between Three Dimensional Conformal and Intensity-modulated Radiotherapies (5 and 7 fields) in Gastric Cancer Post-surgery
下载PDF
导出
摘要 The purpose of this study was to compare the dose distribution of intensity-modulated ra- diotherapy (IMRT) in 7 and 5 fields as well as 3-D conformal radiotherapy (3D-CRT) plans for gastric cancer using dosimetric analysis. In 15 patients with gastric cancer after D1 resection, dosimetric pa- rameters for IMRT (7 and 5 fields) and 3D-CRT were calculated with a total dose of 45 Gy (1.8 Gy/day) These parameters included the conformal index (CI), homogeneity index (HI), maximum dose spot for the planned target volume (PTV), dose-volume histogram (DVH) and dose distribution in the organs at risk (OAR), mean dose (Dmean), maximal dose (Dmax) in the spinal cord, percentage of the normal liver volume receiving more than 30 Gy (V30) and percentage of the normal kidney volume receiving more than 20 Gy (V20). IMRT (7 and 5 fields) and 3D-CRT achieved the PTV coverage. However, IMRT presented significantly higher CI and HI values and lower maximum dose spot distribution than 3D-CRT (P=0.001). For dose distribution of OAR, IMRT had a significantly lower Dmean and Dmax in spinal cord than 3D-CRT (P=-0.009). There was no obvious difference in V30 of liver and V20 of kidney between IMRT and 3D-CRT, but 5-field IMRT showed lower Dmean in the normal liver than other two plans (P=0.001). IMRT revealed favorable tumor coverage as compared to 3D-CRT and IMRT plans. Specifically, 5-field IMRT plan was superior to 3D-CRT in protecting the spinal cord and liver, but this superiority was not observed in the kidney. Further studies are needed to compare differences among the three approaches. The purpose of this study was to compare the dose distribution of intensity-modulated ra- diotherapy (IMRT) in 7 and 5 fields as well as 3-D conformal radiotherapy (3D-CRT) plans for gastric cancer using dosimetric analysis. In 15 patients with gastric cancer after D1 resection, dosimetric pa- rameters for IMRT (7 and 5 fields) and 3D-CRT were calculated with a total dose of 45 Gy (1.8 Gy/day) These parameters included the conformal index (CI), homogeneity index (HI), maximum dose spot for the planned target volume (PTV), dose-volume histogram (DVH) and dose distribution in the organs at risk (OAR), mean dose (Dmean), maximal dose (Dmax) in the spinal cord, percentage of the normal liver volume receiving more than 30 Gy (V30) and percentage of the normal kidney volume receiving more than 20 Gy (V20). IMRT (7 and 5 fields) and 3D-CRT achieved the PTV coverage. However, IMRT presented significantly higher CI and HI values and lower maximum dose spot distribution than 3D-CRT (P=0.001). For dose distribution of OAR, IMRT had a significantly lower Dmean and Dmax in spinal cord than 3D-CRT (P=-0.009). There was no obvious difference in V30 of liver and V20 of kidney between IMRT and 3D-CRT, but 5-field IMRT showed lower Dmean in the normal liver than other two plans (P=0.001). IMRT revealed favorable tumor coverage as compared to 3D-CRT and IMRT plans. Specifically, 5-field IMRT plan was superior to 3D-CRT in protecting the spinal cord and liver, but this superiority was not observed in the kidney. Further studies are needed to compare differences among the three approaches.
机构地区 Department of Oncology
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2013年第5期759-764,共6页 华中科技大学学报(医学英德文版)
关键词 gastric cancer radiation therapy three-dimensional treatment planning system inten-sity-modulated radiotherapy DOSIMETRY gastric cancer radiation therapy three-dimensional treatment planning system inten-sity-modulated radiotherapy dosimetry
  • 相关文献

参考文献1

二级参考文献59

  • 1[1]Siewert JR,Bottcher K,Stein HJ,Roder JD.Relevant prognostic factors in gastric cancer:ten-year results of the German Gastric Cancer Study.Ann Surg 1998; 228:449-461
  • 2[2]Sasako M.Principles of surgical treatment for curable gastric cancer.J Clin Oncol 2003; 21:274s-275s
  • 3[3]Moehler M,Schimanski CC,Gockel I,Junginger T,Galle PR.(Neo)adjuvant strategies of advanced gastric carcinoma:time for a change? Dig Dis 2004; 22:345-350
  • 4[4]Sotiropoulos GC,Kaiser GM,Lang H,Treckmann J,Brokalaki EI,Pottgen C,Gerken G,Paul A,Broelsch CE.Staging laparoscopy in gastric cancer.Eur J Med Res 2005;10:88-91
  • 5[5]Ott K,Fink U,Becket K,Stahl A,Dittler HJ,Busch R,Stein H,Lordick F,Link T,Schwaiger M,Siewert JR,Weber WA.Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging:results of a prospective trial.J Clin Oncol 2003; 21:4604-4610
  • 6[6]Pfau PR,Chak A.Endoscopic ultrasonography.Endoscopy 2002; 34:21-28
  • 7[7]Chen CH,Yang CC,Yeh YH.Preoperative staging of gastric cancer by endoscopic ultrasound:the prognostic usefulness of ascites detected by endoscopic ultrasound.J Clin Gastroenterol 2002; 35:321-327
  • 8[8]Denzer U,Hoffmann S,Helmreich-Becker I,Kauczor HU,Thelen M,Kanzler S,Galle PR,Lohse AW.Minilaparoscopy in the diagnosis of peritoneal tumor spread:prospective controlled comparison with computed tomography.Surg Endosc 2004; 18:1067-1070
  • 9[9]Lordick F,Ott K,Krause BJ,Weber WA,Becket K,Stein HJ,Lorenzen S,Schuster T,Wieder H,Herrmann K,Bredenkamp R,Hofler H,Fink U,Peschel C,Schwaiger M,Siewert JR.PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction:the MUNICON phase Ⅱ trial.Lancet Oncol 2007; 8:797-805
  • 10[10]Bozzetti F,Marubini E,Bonfanti G,Miceli R,Piano C,Gennari L.Subtotal versus total gastrectomy for gastric cancer:five-year survival rates in a multicenter randomized Italian trial.Italian Gastrointestinal Tumor Study Group.Ann Surg 1999; 230:170-178

共引文献16

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部